|
|
|
11 Jul 2006 |
BioMimetic Therapeutics Successfully Completes Enrollment in Three Orthopedic Pilot Clinical Trials for GEM OS1(TM) Bone Graft; Canadian Study Expanded to 60 Patients
|
|
10 Jul 2006 |
BioAxone Therapeutic completes patient enrollment for Phase I/IIa trial of Cethrin(R) in treatment of acute spinal cord injury
|
|
10 Jul 2006 |
European Commission Approves Revision Of Therapeutic Indication For Rebif
|
|
08 Jul 2006 |
Amarillo Biosciences Submits Investigational New Drug Application to Test Oral Interferon in Idiopathic Pulmonary Fibrosis
|
|
06 Jul 2006 |
Nuvelo Announces Publication of Phase 2 Alfimeprase Study Results in Central Venous Catheter Occlusion
|
|
06 Jul 2006 |
Celliance Enters Agreement with Novozymes A/S to Develop Animal-Free Recombinant human Albumin
|
|
05 Jul 2006 |
OctoPlus obtains full rights to OP-145 for the treatment of chronic middle ear infection and other indications
|
|
01 Jul 2006 |
Phosphagenics receives ethics approval for Phase I clinical trials of its transdermal insulin delivery product
|
|
30 Jun 2006 |
PAION shifts start of Phase I study with Solulin to Q4/2006
|
|
30 Jun 2006 |
BioPartners remains positive after Alpheon CHMP ruling
|
|
30 Jun 2006 |
Campus Vienna Biocenter: Training & Dissemination Centre on RNA Viruses launched
|
|
30 Jun 2006 |
STADA: Approval documents for Erythropoietin biosimilar submitted to EMEA
|
|
30 Jun 2006 |
Acologix’ AC-100 (Dentonin) Phase II Data On Dentin Formation In Humans Presented At The Annual Meeting Of The International Association For Dental Research
|
|
28 Jun 2006 |
Neose Discloses Proteins Under License Agreements With Novo Nordisk
|
|
28 Jun 2006 |
Talecris Biotherapeutics Announces Start of Licensing Clinical Trials for Alpha-1 Antitrypsin Using Modified Manufacturing Process
|
|
28 Jun 2006 |
Nastech Scientific Abstracts Presented at the American Association of Pharmaceutical Scientists (AAPS) National Biotechnology Conference
|
|
28 Jun 2006 |
Insmed Presents Positive IPLEX(TM) Data At ENDO 2006
|
|
27 Jun 2006 |
Presentations of ConjuChem's Novel Growth Hormone Therapeutic Highlighted at the 88th Annual Meeting of the Endocrine Society
|
|
27 Jun 2006 |
Affymax and Takeda Announce Comprehensive Global Agreement for Development and Commercialization of Hematide(TM) for Anemia
|
|
27 Jun 2006 |
Nastech Pharmaceutical Company Inc. Enters into Development and License Agreement With Amylin Pharmaceuticals, Inc.
|
|
27 Jun 2006 |
Nastech's Parathyroid Hormone (PTH1-34) Nasal Spray Demonstrated Similar Exposure Levels to Approved Injectable Product in Phase I Study in the Elderly
|
|
27 Jun 2006 |
Enrollment in Phase III Clinical Trial for OMRIX's Thrombin Stand-Alone Product Has Been Completed
|
|
24 Jun 2006 |
Altus Pharmaceuticals Announces Positive Results from Phase II Study in Growth Hormone Deficient Patients with Once-per-Week Growth Hormone
|
|
23 Jun 2006 |
Savient's Puricase(R) (PEG-uricase) Phase 2 Results Show Powerful Anti-hyperuricemic Activity in Treatment-Failure Gout Patients
|
|
22 Jun 2006 |
NeoPharm Announces PRECISE Trial Update; Independent Data Monitoring Committee Recommends PRECISE Trial Continue to Final Efficacy Analysis
|
|
22 Jun 2006 |
First Adnectin Therapeutic, CT-322, Clears FDA IND Review To Start Clinical Trials
|
|
22 Jun 2006 |
QSV Biologics, Ltd., and Proteon Therapeutics, Inc., Enter into a Contract for Process Development and Manufacture of PRT-201
|
|
22 Jun 2006 |
Acceleron Initiates Phase 1 Clinical Trial of ACE-011, a Novel Treatment for Bone Loss
|
|
21 Jun 2006 |
AEterna Zentaris Receives Green Light from FDA to Move Forward into Phase 3 Program with Cetrorelix in BPH
|
|
21 Jun 2006 |
Auxilium Pharmaceuticals Announces Top-Line Results from a Pivotal Efficacy Study of AA4500 in Dupuytren's Disease and Revises 2006 Financial Guidance
|
|
21 Jun 2006 |
Scigen Strengthens Position As A Global Manufacturer Of Biosimilars Following Acquisition Of GCSF And EPO
|
|
21 Jun 2006 |
Moapar 3 Months Approved For The Lowering Of Testosterone To Castrate Serum Levels For Control Of Sexual Drive In Adult Men
|
|
21 Jun 2006 |
ConjuChem Successfully Completes Patient Enrollment of its Phase II Trial of DAC(TM):GRF for Treatment of HIV Lipodystrophy
|
|
20 Jun 2006 |
ZymoGenetics Completes Enrollment for rhThrombin Phase 3 Trial
|
|
20 Jun 2006 |
Acologix and Toray Announce Partnership on AC-200 (Phosphatonin)
|
|
19 Jun 2006 |
Final Results of Phase 2 Clinical Trial Program Suggest Treatment of Anemia with Aranesp(R) (Darbepoetin Alfa) May Decrease Risk of Hospitalization and All-Cause Mortality in Heart Failure Patients with Anemia, Based on a Prespecified Pooled Analysis
|
|
17 Jun 2006 |
Renegotiated Licensing Agreement For Human Insulin Postions Scigen Strongly For International Sales Growth
|
|
16 Jun 2006 |
Innovative Technology for Treatment of Renal Anaemia Unveiled Today
|
|
15 Jun 2006 |
Discovery Labs' Surfaxin Granted Orphan Drug Designation for the Prevention of Bronchopulmonary Dysplasia
|
|
15 Jun 2006 |
Savient Pharmaceuticals Initiates Patient Dosing for Puricase(R) Phase 3 Clinical Study; Company on track for BLA filing in late 2007
|
|
14 Jun 2006 |
Pharming Recieves Orphan Drug Designations For rhC1INH From US FDA
|
|
14 Jun 2006 |
ConjuChem's PC-DAC(TM):Exendin-4 presented at the American Diabetes Association annual meeting
|
|
14 Jun 2006 |
CeraPedics Announces Results of P-15(TM) Non-Union/Delayed Union Pilot Study Published in International Orthopaedics
|
|
13 Jun 2006 |
Study of over 10,000 patients indicates that Levemir® effectively treats diabetes safely and without causing weight gain
|
|
13 Jun 2006 |
Liraglutide Phase 2 Study Shows Increased Insulin Secretion and Improved Blood Glucose Control in People with Type 2 Diabetes
|
|
13 Jun 2006 |
PharmAthene Presents Data on Recombinant Human Butyrylcholinesterase Program at Bioscience Review 2006
|
|
13 Jun 2006 |
FDA Approves Investigational New Drug Application
|
|
13 Jun 2006 |
Oramed Pharmaceuticals Combats Diabetes with Oral Insulin
|
|
11 Jun 2006 |
Data on AIR Inhaled Insulin System Presented at American Diabetes Association Meeting
|
|
11 Jun 2006 |
BYETTA(R) Shown to Reduce Blood Glucose Levels When Added to Patients Using a TZD
|
| |
|
Results 1151 - 1200 of 1426 |
